Page 113 - 2026 SMOG
P. 113

DIAZEPAM (VALIUM)
                              Class/Mechanism of Action
         •  Benzodiazepine
           Acts as an Anxiolytic/Hypnotic, anticonvulsant, and sedative.
              ˚  Long Half Life: 25–100hr; Onset of action—IV: Almost Immediate; Duration—IV: 20–30min
                                    Indications
         •  Labeled Indications
             Anxiety disorders
              ˚ Convulsive Disorders and Alcohol Withdrawal Symptoms
              ˚ Skeletal muscle relaxant
              ˚   ˚ Induce sedation and amnesia (Midazolam is the primary medication)
                                  Contraindications
         •  Hypersensitivity to Diazepam or any component of the formulation or other benzodiazepines
         •  Acute narrow—angle glaucoma
         •  Untreated open—angle glaucoma
                            Adverse Reactions/Precautions
         •  No Analgesic properties (Narcotic pain control is needed for RSI/Intubated trauma patients)
         •  May Cause Respiratory depression: Do not give without a stable IV line and BVM (airway control) ready.
         •  Hypotension, vasodilation
         •  Amnesia, confusion, drowsiness, slurred speech (Paradoxical reactions possible: aggressiveness,
           agitation, anxiety, inappropriate behavior)
         •  Pregnancy: Category D
         •  Lactation: Not Recommended
                                Dose/Administration
                                                     PEDIATRIC
                      ADULT
                                               (Always reference Broselow Tape)
         Anxiety                         Sedation/Muscle Relaxation/Anxiety
         •  Oral/IV/IM (oral and IV doses more reliable)  •  IV/IM (IV doses more reliable)
             2–10mg q3–6hr prn (max DAILY dose:    Infants & Children: 0.05–0.1mg/kg over
              ˚ 40mg/day)                     ˚ 3–5min, titrate slowly to effect (max TOTAL
         Status Epilepticus/Seizures         dose: 0.25mg/kg)
         •  IV (SLOW)                        Adolescents: 5mg IV; may repeat with 2.5mg
             5–10mg over 2min; repeat q3–5min prn      ˚ if needed
              ˚ (max TOTAL dose: 30mg for acute seizures)  Status Epilepticus
         Sedation in ICU Patient         •  IV
         •  IV                               0.15–0.20mg/kg/dose to a max of 10mg/dose;
             Loading dose: 5–10mg             ˚ may repeat dose once in 5min
              ˚ Maintenance dose: 0.03–0.1mg/kg q30min   Muscle Spasm Associated with Tetanus
              ˚ to 6hr                   •  IV/IM
         Muscle Spasm Associated with Tetanus  Infants >30 days and Children <5 years:
         •  IV                                ˚ 1–2mg q3–4hr prn
              ˚  Initial: 10–30mg q1–4hr prn    ˚  Children ≥5 years: 5–10mg q3–4hr prn
         Nerve Agent Exposure (CBRNE)
         •  IV
             10–20mg for seizures associated with Nerve
              ˚ Agent exposure (up to 40mg may be needed)
         •  IM
             Administer 3 ATNAA (atropine/2-Pam
              ˚ autoinjector) and 1 CANA (10mg Diazepam
             autoinjector)
                          2026 Standard Medical Operating Guidelines (SMOG)  •   105
   108   109   110   111   112   113   114   115   116   117   118